Patient Barriers to and Enablers of Deprescribing: a Systematic Review
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Background Inappropriate medication use is common in the elderly and the risks associated with their use are well known. The term deprescribing has been utilised to describe the complex process that is required for the safe and effective cessation of inappropriate medications. Given the primacy of the consumer in health care, their views must be central in the development of any deprescribing process.Objectives The aim of this study was to identify barriers and enablers that may influence a patient's decision to cease a medication.Data sources A systematic search of MEDLINE, International Pharmaceutical Abstracts, EMBASE, CINAHL, Informit and Scopus was conducted and augmented with a manual search. Numerous search terms relating to withdrawal of medications and consumers' beliefs were utilised.Study eligibility criteria Articles were included if the barriers or enablers were directly patient/carer reported and related to long-term medication(s) that they were currently taking or had recently ceased.Study appraisal and synthesis methods Determination of relevance and data extraction was performed independently by two reviewers. Content analysis with coding was utilised for synthesis of results.Results Twenty-one articles met the criteria and were included in the review. Three themes, disagreement/agreement with 'appropriateness' of cessation, absence/presence of a 'process' for cessation, and negative/positive 'influences' to cease medication, were identified as both potential barriers and enablers, with 'fear' of cessation and 'dislike' of medications as a fourth barrier and enabler, respectively. The most common barrier/enabler identified was 'appropriateness' of cessation, with 15 studies identifying this as a barrier and 18 as an enabler.Conclusions and implications of key findings The decision to stop a medication by an individual is influenced by multiple competing barriers and enablers. Knowledge of these will aid in the development of a deprescribing process, particularly in approaching the topic of cessation with the patient and what process should be utilised. However, further research is required to determine if the proposed patient-centred deprescribing process will result in improved patient outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, many patients indicate they would be open to considering tapering chronic medications, including BZDs, if clinicians discussed it with them.66,67”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [66]
In the citing paper
“Although some patients will be understandably reluctant to consider tapering a medication they have been taking for a long period of time and consider helpful, others may welcome the opportunity to minimize potential adverse effects and explore more optimal ways of managing their underlying conditions.65,66”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [66]
In the citing paper
“Patients who have used BZDs for a long time may be reluctant to taper the medication due to fear of experiencing adverse effects related to discontinuation.66,151,152”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [66]
Citations
Cites
Tong, A., Sainsbury, P., & Craig, J. (2007) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzm042 · Cited by 42,509 · cited 2×
“Reporting of these criteria allows the reader to assess the quality and potential bias within the study [31].”
Qualitative research in health care: Assessing quality in qualitative research
Mays, N. (2000) · BMJ · doi:10.1136/bmj.320.7226.50 · Cited by 3,742
Hesse, B. W., Nelson, D. E., Kreps, G. L., Croyle, R. T., Arora, N. K., Rimer, B. K., & Viswanath, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2618 · Cited by 1,523 · cited 1×
“This may be due to the studies being conducted many years previous when Internet was less ubiquitous, or the majority of participants in the studies being elderly who are not as Internet-literate (and less trusting of the Internet) as the younger population, and report that they still prefer to get a majority of their…”
BackgroundGuidance on the conduct of narrative synthesis in sytematic reviews
Popay, J., Roberts, H. M., Sowden, A. J., Petticrew, M. P., Arai, L., Rodgers, M., & Britten, N. (2006) · Cited by 1,363
How can systematic reviews incorporate qualitative research? A critical perspective
Dixon-Woods, M., Bonas, S., Booth, A., Jones, D. R., Miller, T., Sutton, A. J., Shaw, R. L., Smith, J. A., & Young, B. (2006) · Qualitative Research · doi:10.1177/1468794106058867 · Cited by 860 · cited 2×
“tative studies is not appropriate [28, 30].”
MethodBannister, S. J. (2009) · Cited by 751
Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe
Fialová, D. (2005) · JAMA · doi:10.1001/jama.293.11.1348 · Cited by 707
Polypharmacy and Prescribing Quality in Older People
Steinman, M. A., Seth Landefeld, C., Rosenthal, G. E., Berthenthal, D., Sen, S., & Kaboli, P. J. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00889.x · Cited by 537 · cited 3×
“Around 20–60 % of elderly patients are taking at least one potentially inappropriate medication (PIM), defined as a medication where the potential risks associated with use outweigh the potential benefits [1–4].”
BackgroundInappropriate Prescribing: Criteria, Detection and Prevention
OʼConnor, M. N., Gallagher, P., & OʼMahony, D. (2012) · Drugs & Aging · doi:10.2165/11632610-000000000-00000 · Cited by 351
Medication Withdrawal Trials in People Aged 65 Years and Older: A Systematic Review
Iyer, S., Naganathan, V., McLachlan, A. J., & Le Couteur, D. G. (2008) · Drugs & Aging · doi:10.2165/0002512-200825120-00004 · Cited by 339 · cited 4×
“The percentages of patients who have to restart medications due to return of condition are unknown for most medication classes, and the risk of a condition returning in an individual patient cannot be predicted [13].”
BackgroundInfluentialIncluding qualitative research in systematic reviews: opportunities and problems
Dixon‐Woods, M., Fitzpatrick, R., & Roberts, K. (2001) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.2001.00257.x · Cited by 298 · cited 1×
“tative studies is not appropriate [28, 30].”
Interventions that can Reduce Inappropriate Prescribing in the Elderly: A Systematic Review
Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009) · Drugs & Aging · doi:10.2165/11318890-000000000-00000 · Cited by 290 · cited 1×
“These interventions have shown some benefits, including reduction in polypharmacy, PIMs, and costs associated with medication use [9, 10].”
BackgroundSelf-citationDeprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications
Woodward, M. C. (2003) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr2003334323 · Cited by 287 · cited 2×
“improvement of the patient-professional relationship and patient adherence [11, 12].”
BackgroundSchuling, J., Gebben, H., Veehof, L. J. G., & Haaijer-Ruskamp, F. M. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-56 · Cited by 249 · cited 1×
“In addition to time limitations, factors that affect physicians’ willingness and ability to deprescribe include beliefs concerning patients, guidelines for treatment and organisation of health care [67].”
BackgroundPatients' decisions about whether or not to take antihypertensive drugs: qualitative study
Benson, J. (2002) · BMJ · doi:10.1136/bmj.325.7369.873 · Cited by 246 · cited 10×
“Other studies reported that the patient may agree with appropriateness of cessation because of mistrust in the original prescriber who initiated the medication [38, 52].”
BackgroundInfluentialPeople's Attitudes, Beliefs, and Experiences Regarding Polypharmacy and Willingness to Deprescribe
Reeve, E., Wiese, M. D., Hendrix, I., Roberts, M. S., & Shakib, S. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12418 · Cited by 221
Self-citationGnjidic, D., Le Couteur, D. G., Kouladjian, L., & Hilmer, S. N. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.006 · Cited by 215 · cited 1×
“These interventions have shown some benefits, including reduction in polypharmacy, PIMs, and costs associated with medication use [9, 10].”
BackgroundDimitrow, M. S., Airaksinen, M. S. A., Kivelä, S., Lyles, A., & Leikola, S. N. S. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03497.x · Cited by 203 · cited 1×
“More commonly though, it is through increased risk that a medication becomes inappropriate [8].”
BackgroundViews of Older Persons with Multiple Morbidities on Competing Outcomes and Clinical Decision‐Making
Fried, T. R., McGraw, S., Agostini, J. V., & Tinetti, M. E. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01923.x · Cited by 203 · cited 1×
“Since patients have been shown to consider competing outcomes when deciding on treatment options [25] it is therefore likely that the same occurs when medication cessation is proposed.”
BackgroundInappropriate medication use among the elderly: a systematic review of administrative databases
Guaraldo, L., Cano, F. G., Damasceno, G. S., & Rozenfeld, S. (2011) · BMC Geriatrics · doi:10.1186/1471-2318-11-79 · Cited by 203 · cited 2×
“(2 0 0 7 ) [4 1 ] S S R Is U K Q u al it at iv e S em ist ru ct u re d”
BackgroundBain, K. T., Holmes, H. M., Beers, M. H., Maio, V., Handler, S. M., & Pauker, S. G. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01916.x · Cited by 198 · cited 1×
“with or without tapering) and monitoring, support and review [11, 12, 15–18].”
BackgroundStep-down management of gastroesophageal reflux disease
Inadomi, J. M., Jamal, R., Murata, G. H., Hoffman, R. M., Lavezo, L. A., Vigil, J. M., Swanson, K. M., & Sonnenberg, A. (2001) · Gastroenterology · doi:10.1053/gast.2001.28649 · Cited by 192
Overuse of proton pump inhibitors
Naunton, M., Peterson, G. M., & Bleasel, M. D. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00312.x · Cited by 183
Minimizing Inappropriate Medications in Older Populations: A 10-step Conceptual Framework
Scott, I. A., Gray, L., Martin, J. H., & Mitchell, C. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.021 · Cited by 156 · cited 1×
“with or without tapering) and monitoring, support and review [11, 12, 15–18].”
BackgroundAdverse Events After Discontinuing Medications in Elderly Outpatients
Graves, T. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.19.2205 · Cited by 152 · cited 1×
“ceased; however, most of these events do not result in significant harm [13, 60].”
BackgroundBashir, K., King, M., & Ashworth, M. J. (1994) · Europe PMC (PubMed Central) · Cited by 143
Problems with Medication Use in the Elderly: An Australian Perspective
Elliott, R. A. (2006) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2006.tb00889.x · Cited by 141 · cited 3×
“(2 0 0 1 ) [3 2 ] A n y lo n g -t er m”
BackgroundSystematic Review of Interventions to Improve Prescribing
Ostini, R., Hegney, D., Jackson, C., Williamson, M., Mackson, J. M., Gurman, K., Hall, W., & Tett, S. E. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l488 · Cited by 141 · cited 1×
“Patient and primary care physician engagement is essential for successful cessation of a prescribed medicine [19].”
BackgroundIncident use and outcomes associated with potentially inappropriate medication use in older adults
Dedhiya, S. D., Hancock, E., Craig, B. Α., Doebbeling, C. C., & Thomas, J. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(10)80005-4 · Cited by 139 · cited 1×
“Use of PIMs has been correlated with worsened outcomes for the patient, including an increased risk of adverse drug reactions (ADRs), hospitalisation and mortality [5, 6].”
BackgroundWilliams, M. E., Pulliam, C. C., Hunter, R., Johnson, T. M., Owens, J. E., Kincaid, J., Porter, C., & Koch, G. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52016.x · Cited by 136 · cited 1×
“However, there is some evidence to suggest that there is reluctance to cease specific medications in practice [21], and patient refusal to cease identified PIMs may be as high as 67 % [22].”
BackgroundDevelopment and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire
Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9704-5 · Cited by 116 · cited 1×
“In fact, belief in the necessity of their medications has previously been found to be inversely associated with a desire to decrease the number of medications that they are taking [54].”
BackgroundSelf-citationInappropriate Medication Use as a Risk Factor for Self‐Reported Adverse Drug Effects in Older Adults
Chrischilles, E. A., VanGilder, R., Wright, K., Kelly, M., & Wallace, R. B. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02269.x · Cited by 110 · cited 1×
“Use of PIMs has been correlated with worsened outcomes for the patient, including an increased risk of adverse drug reactions (ADRs), hospitalisation and mortality [5, 6].”
BackgroundCook, J. M., Biyanova, T., Masci, C., & Coyne, J. C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0205-5 · Cited by 107 · cited 5×
“pragmatic reasons, such as, ‘the medication is not as bad as other ones out there’ [52], ‘I am old so why change things’ [34], habit [33] and not wanting to have one’s mind occupied with the process of cessation (i.”
BackgroundInfluentialUsing stimulant medication for children with ADHD: what do parents say? A brief report.
Charach, A., Skyba, A., Cook, L., & Antle, B. J. (2006) · PubMed · Cited by 106
Rational Prescribing for Patients With a Reduced Life Expectancy
Holmes, H. M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.211 · Cited by 106 · cited 1×
“The elderly are known to experience more ADRs due to age-related changes in pharmacokinetics and pharmacodynamics, and every new medication and medical condition has the potential to interact with existing medications [7].”
BackgroundRoe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009) · Psychiatric Rehabilitation Journal · doi:10.2975/33.1.2009.38.46 · Cited by 99 · cited 7×
“Other studies reported that the patient may agree with appropriateness of cessation because of mistrust in the original prescriber who initiated the medication [38, 52].”
BackgroundInfluentialZermansky, A. G. (1996) · Europe PMC (PubMed Central) · Cited by 98
Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis
Parr, J. M., Kavanagh, D. J., Young, R. M., & McCafferty, K. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.07.016 · Cited by 95 · cited 9×
“The remaining 11 articles [32–37, 41, 44, 48–50] had the viewpoint of encouragement of discontinuation, often where the medication in question was viewed to be either over-used or commonly inappropriately used (e.g. BZDs for insomnia in the elderly [34]).”
BackgroundInfluentialQualitative research in medicine and health care: Questions and controversy
Poses, P. M., & Isen, A. M. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00005.x · Cited by 92 · cited 1×
“Most qualitative researchers agree that bias is unavoidable as it is entwined with the methods utilised and highly linked to the individual researcher conducting the study [72].”
MethodDo antidepressants have any potential to cause addiction?
Haddad, P. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300321 · Cited by 89 · cited 1×
“While abrupt cessation of these medications can lead to withdrawal effects, they are not associated with (medically defined) addiction [58].”
BackgroundLeydon, G. M., Rodgers, L., & Kendrick, T. (2007) · Family Practice · doi:10.1093/fampra/cmm069 · Cited by 85 · cited 10×
“The medication classes/therapeutic groups studied were BZDs (5) [33–37], psychotropic medication (2) [38, 39], depression/anxiety medications [40], selective serotonin reuptake inhibitors (SSRIs) (2) [41, 42], donepezil [43], methadone [44], antiepileptics [45], hormone replacement therapy (HRT) (3) [46–48], proton pu…”
BackgroundInfluentialA pilot randomized controlled trial of deprescribing
Etherton‐Beer, C., Loh, P., Peng, Y. G., Potter, K., & Millar, J. A. (2011) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098611400332 · Cited by 84 · cited 1×
“However, there is some evidence to suggest that there is reluctance to cease specific medications in practice [21], and patient refusal to cease identified PIMs may be as high as 67 % [22].”
BackgroundVerbeek-Heida, P. M., & Mathot, E. F. (2006) · Chronic Illness · doi:10.1177/17423953060020020801 · Cited by 75 · cited 14×
“The medication classes/therapeutic groups studied were BZDs (5) [33–37], psychotropic medication (2) [38, 39], depression/anxiety medications [40], selective serotonin reuptake inhibitors (SSRIs) (2) [41, 42], donepezil [43], methadone [44], antiepileptics [45], hormone replacement therapy (HRT) (3) [46–48], proton pu…”
BackgroundInfluentialKrol, N. P. C. M., Wensing, M., Haaijer‐Ruskamp, F. M., Muris, J. W. M., Numans, M. E., Schattenberg, G., van Balen, J., & Grol, R. P. T. M. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01928.x · Cited by 74
Gnjidic, D., Couteur, D. G. L., Abernethy, D. R., & Hilmer, S. N. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p310 · Cited by 72 · cited 1×
“In order to develop a safe and effective deprescribing process, factors that influence a patient’s decision to cease a medication must be known [23, 24].”
BackgroundPredictors and Mediators of Successful Long-term Withdrawal From Antihypertensive Medications
Espeland, M. A. (1999) · Archives of Family Medicine · doi:10.1001/archfami.8.3.228 · Cited by 70
Iliffe, S., Curran, H. V., Collins, R., Yuen Kee, S. C., Fletcher, S., & Woods, B. (2004) · Aging & Mental Health · doi:10.1080/13607860410001669778 · Cited by 67 · cited 3×
“The sub-theme of ‘psychological benefits of ceasing’ resulted from patient expressions of wanting to be more in control of their life [35], the desire to be ‘normal’ [45], preferring themselves without the medication [39] and others.”
BackgroundMethodThe long-term use of benzodiazepines: patients' views, accounts and experiences
Barter, G., & Cormack, M. (1996) · Family Practice · doi:10.1093/fampra/13.6.491 · Cited by 67
Do patients' expectations influence their use of medications? Qualitative study.
Dolovich, L., Nair, K., Sellors, C., Lohfeld, L. H., Lee, A., & Levine, M. (2008) · PubMed · Cited by 65
Patients' experiences of medication for anxiety and depression: Effects on working life
Haslam, C. (2004) · Family Practice · doi:10.1093/fampra/cmh218 · Cited by 63 · cited 4×
“A majority of the included studies had participants who expressed non-specific fears, such as ‘concerned about negative consequences of stopping’ [34], ‘stopping being seen as problematic’ [33] and ‘not sure that they would cope’ [40].”
BackgroundInfluentialThe rise and rise of proton pump inhibitor drugs: Patients' perspectives
Boath, E., & Blenkinsopp, A. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00094-4 · Cited by 61
Le Couteur, D., Banks, E., Gnjidic, D., & McLachlan, A. (2011) · Australian Prescriber · doi:10.18773/austprescr.2011.095 · Cited by 60
Deprescribing in the Last Year of Life
Hardy, J. E., & Hilmer, S. N. (2011) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2011.tb00684.x · Cited by 58
Proton pump inhibitors: perspectives of patients and their GPs.
Grime, J., Pollock, K., & Blenkinsopp, A. (2001) · Europe PMC (PubMed Central) · Cited by 56
Long term use of benzodiazepines: the views of patients.
King, M., Gabe, J., Williams, P. R., & Rodrigo, E. K. (1990) · Europe PMC (PubMed Central) · Cited by 54
Moses, T. (2010) · Child Psychiatry & Human Development · doi:10.1007/s10578-010-0209-y · Cited by 44 · cited 8×
“The articles were mostly qualitative in design (13) [33, 34, 36–38, 40–43, 45, 49, 50, 52], some utilised both qualitative and quantitative elements (7) [32, 35, 39, 44, 46, 47, 51] and one was purely quantitative [48].”
BackgroundMethodInfluentialTapering from methadone maintenance: Attitudes of clients and staff
Gold, M. L. (1988) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(88)90037-2 · Cited by 39 · cited 5×
“The articles were mostly qualitative in design (13) [33, 34, 36–38, 40–43, 45, 49, 50, 52], some utilised both qualitative and quantitative elements (7) [32, 35, 39, 44, 46, 47, 51] and one was purely quantitative [48].”
BackgroundMethodInfluentialPost, S. G., Stuckey, J. C., Whitehouse, P. J., Ollerton, S., Durkin, C., Robbins, D., & FallCreek, S. J. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200104000-00007 · Cited by 36 · cited 5×
“Six of the articles [39, 42, 43, 45, 46, 52] conducted their studies without the conception that either continuation or discontinuation of the medication was desired (their purpose was to improve knowledge to aid in better care of patients with the medical conditions that these medications were used to treat).”
BackgroundInfluentialPrioritizing and stopping prescription medicines
Alexander, G. C. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050837 · Cited by 35 · cited 1×
“with or without tapering) and monitoring, support and review [11, 12, 15–18].”
BackgroundKnowing How to Stop: Ceasing Prescribing When the Medicine Is No Longer Required
Ostini, R., Hegney, D. G., Jackson, C. L., & Tett, S. E. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.1.68 · Cited by 33 · cited 1×
“with or without tapering) and monitoring, support and review [11, 12, 15–18].”
BackgroundStopping long-term drug therapy in general practice. How well do physicians and patients agree?
Straand, J., & Sandvik, H. (2001) · Family Practice · doi:10.1093/fampra/18.6.597 · Cited by 32 · cited 3×
“Of the 21 included studies, 20 focused on a single medication class or therapeutic group, while the remaining study included participants on any long-term drug therapy (Table 1) [32].”
BackgroundMethodLong-term use of benzodiazepines.
Gorgels, W. J. M. J., Voshaar, R. C. O., Mol, A. J., BRETELER, M. H. M., van de Lisdonk, E. H., & Zitman, F. G. (1990) · PubMed Central · Cited by 31
Raghunath, A. S., Hungin, A. P. S., Cornford, C. S., & Featherstone, V. (2005) · Digestion · doi:10.1159/000089727 · Cited by 31 · cited 6×
“The medication classes/therapeutic groups studied were BZDs (5) [33–37], psychotropic medication (2) [38, 39], depression/anxiety medications [40], selective serotonin reuptake inhibitors (SSRIs) (2) [41, 42], donepezil [43], methadone [44], antiepileptics [45], hormone replacement therapy (HRT) (3) [46–48], proton pu…”
BackgroundInfluentialThe experience of discontinuing antiepileptic drug treatment: An exploratory investigation
Kılınç, S., & Campbell, C. (2008) · Seizure · doi:10.1016/j.seizure.2008.01.002 · Cited by 30 · cited 10×
“Two articles reported a non-specific scepticism of a recommendation to cease, one participant perceiving that their primary care physician was not up-to-date on the most recent evidence (in relation to cessation of antiepileptics) [45].”
BackgroundInfluentialSpanish post-menopausal women's viewpoints on hormone therapy
Castelo‐Branco, C., Ferrer, J., Palacios, S., Cornago, S., & Peralta, S. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.11.006 · Cited by 28 · cited 6×
“Not surprisingly, the article that reported the media as an influence studied HRT cessation [47].”
BackgroundMethodInfluentialBerger, B. A., Hudmon, K. S., & Liang, H. (2004) · Journal of the American Pharmacists Association · doi:10.1331/1544345041475607 · Cited by 28 · cited 5×
“The articles were mostly qualitative in design (13) [33, 34, 36–38, 40–43, 45, 49, 50, 52], some utilised both qualitative and quantitative elements (7) [32, 35, 39, 44, 46, 47, 51] and one was purely quantitative [48].”
BackgroundMethodInfluentialvan Duijn, H. J., Belo, J. N., Blom, J. W., Velberg, I. D., & Assendelft, W. J. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x578025 · Cited by 21 · cited 1×
“In order to develop a safe and effective deprescribing process, factors that influence a patient’s decision to cease a medication must be known [23, 24].”
BackgroundHering‐Hanit, R., Yavetz, A., & Dagan, Y. (2000) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2000.00146.x · Cited by 21 · cited 1×
“reduction in falls after cessation of psychotropics [13], and decreased headaches and improved sleep on cessation of analgesics [14]), but similar benefits have not been shown consistently across studies and medication classes [13].”
BackgroundA study of women on long-term hormone replacement therapy and their attitude to suggested cessation
Horner, E., Fleming, J., & Studd, J. W. W. (2006) · Climacteric · doi:10.1080/13697130601024629 · Cited by 19 · cited 2×
“[48] reported only barriers) [Table 1].”
MethodMedications in Long-Term Care: When Less is More
Meeks, T. W., Culberson, J. W., & Horton, M. S. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.01.003 · Cited by 18
Patients' evaluation of the appropriateness of their hypertension management—A qualitative study
Morecroft, C. W., Cantrill, J., & Tully, M. P. (2006) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2006.02.006 · Cited by 11 · cited 4×
“Patients taking antihypertensive medications had difficulty understanding the concept of appropriateness and still looked to their doctor to determine if the medication was right for them [56].”
BackgroundInfluentialCompliance with hormone replacement therapy among Swedish women
Berterö, C., & Johansson, G. (2001) · International Nursing Review · doi:10.1046/j.1466-7657.2001.00089.x · Cited by 4 · cited 4×
“Media and the release of new evidence (particularly of the potential risks of medication use) were identified as enablers to deprescribing in two studies [46, 47], both of which included patients taking HRT.”
BackgroundMethodInfluential
Cited by
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Self-citationSkou, S. T., Mair, F. S., Fortin, M., Guthrie, B., Nunes, B. P., Miranda, J. J., Boyd, C. M., Pati, S., Mtenga, S., & Smith, S. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00376-4 · Cited by 1,362
“Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies (via University of North Carolina at Chapel Hill School of Public Health), FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the NewtonPaulet Fund (223-2018, 224-2018), DFID/ MRC/Wellcome Global Health Trials (MR/M007405/1), Fo…”
MethodReeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855
Self-citationAnderson, K., Stowasser, D., Freeman, C., & Scott, I. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006544 · Cited by 725
Page, A. T., Clifford, R. M., Potter, K., Schwartz, D., & Etherton‐Beer, C. D. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12975 · Cited by 496
Metadata
- Authors
- Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D.
- Affiliations
- University of South Australia (AU)
- Repatriation General Hospital (AU)
- Royal Adelaide Hospital (AU)
- The University of Queensland (AU)
- Corresponding author
- Reeve, Emily
- Venue
- Drugs & Aging
- Published
- 2013-08-03
- Volume
- 30
- Issue
- 10
- Pages
- 793-807
- ISSN
- 1170-229X (ISSN-L)
- 1179-1969
- OpenAlex
- W2085842968
- Cited by
- 536
- References
- 72
- Citations by year
- 2026: 25 · 2025: 40 · 2024: 67 · 2023: 36 · 2022: 57 · 2021: 58 · 2020: 59 · 2019: 57 · 2018: 49 · 2017: 29 · 2016: 34 · 2015: 15 · 2014: 10
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Drugs & Aging (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- deprescribing, inappropriate medication use, older adults, patient barriers, patient beliefs, patient-centered care, long-term medication
- MeSH terms
- Decision Making, Humans, Withholding Treatment, Inappropriate Prescribing, Patient Safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.